Sonoma Pharmaceuticals
SNOA
#10409
Rank
ยฃ4.71 M
Marketcap
ยฃ2.77
Share price
-1.20%
Change (1 day)
24.66%
Change (1 year)

Revenue for Sonoma Pharmaceuticals (SNOA)

Revenue in 2025 (TTM): ยฃ12.83 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ12.66 Million. In 2024 the company made a revenue of ยฃ11.13 Million an increase over the revenue in the year 2023 that were of ยฃ9.66 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sonoma Pharmaceuticals from 2005 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ12.83 M15.3%
2024 ยฃ11.13 M15.24%
2023 ยฃ9.66 M-6.9%
2022 ยฃ10.37 M12.19%
2021 ยฃ9.25 M-40.1%
2020 ยฃ15.44 M12.52%
2019 ยฃ13.72 M-4.49%
2018 ยฃ14.37 M14.04%
2017 ยฃ12.6 M26.15%
2016 ยฃ9.99 M4.28%
2015 ยฃ9.58 M16.64%
2014 ยฃ8.21 M-3.84%
2013 ยฃ8.54 M-10.75%
2012 ยฃ9.57 M22.89%
2011 ยฃ7.78 M29.61%
2010 ยฃ6 M47.16%
2009 ยฃ4.08 M23.66%
2008 ยฃ3.3 M61.12%
2007 ยฃ2.04 M-4.88%
2006 ยฃ2.15 M71.05%
2005 ยฃ1.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
ยฃ0.16 M-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.47 B 3,690.91%๐Ÿ‡บ๐Ÿ‡ธ USA